Drugs / BAY85-8501
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT01818544 | Apr 2013 → Jun 2014 | bronchiectasis | Bayer | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | BAY85-8501 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01818544 ↗ |
| Route | Oral | “will be administered orally once daily in the morning” NCT01818544 ↗ |